UBS OCONNOR LLC - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,216,194
-39.5%
117,280
-16.4%
0.03%
-50.8%
Q2 2023$2,008,810
+181.1%
140,280
+40.1%
0.06%
+186.4%
Q1 2023$714,664
-100.0%
100,093
-35.0%
0.02%
-31.2%
Q3 2022$1,707,000,000
+59.1%
154,093
+21.2%
0.03%
+100.0%
Q2 2022$1,073,000,000127,0930.02%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders